population, misclassifying some armed victims as unarmed would probably attenuate our estimates toward the null. Additionally, including misclassified cases would increase the total number of police killings of unarmed black Americans, but this number is likely to be underestimated, given known gaps in existing databases. 1 We also excluded 7·3% of unarmed victims for whom race could not be verified. For these reasons, the true per-event effect on mental health resulting from police killings of unarmed black Americans is probably greater than we reported, and the effect on the total population is unlikely to be meaningfully changed.
Finally, the way in which the MPV database classifies decedents as armed or unarmed was ideal given the research question. Our aim was to estimate how police killings of unarmed black Americans affect the mental health of black Americans in the general US population. Eyewitness accounts are likely to be as important as police reports in shaping perceptions of these events in the community, as well as the extent to which these events reflect structural racism. The fact that 12-yearold Tamir Rice was armed with an Airsoft replica gun did little to assuage concerns in the community about the conduct of former officer Timothy Loehmann.
3 Our analysis demonstrated that the armed status of black American victims of police killings is an important moderator of their effect on population health. Understanding the meaning ascribed to unarmed versus armed status and how this meaning shapes population health is an important topic for future research.
We declare no competing interests. 
Authors' reply
Police killings are inaccurately measured in official statistics. 1 Citizen-compiled databases such as Mapping Police Violence (MPV) thus offer important public-health surveillance of these events. Although some degree of misclassification of exposure is possible, it is improbable to have substantially affected our estimates or conclusions. 2 We chose the MPV database over other similar databases for several reasons. First, the MPV database dates back to 2013, whereas the databases by The Washington Post and The Guardian only date back to 2015. The MPV database could therefore be matched to the largest set of outcome data available to us through the Behavioral Risk Factor Surveillance System database at the time we initiated the study. Second, the MPV database includes all police killings, not just police shootings. Third, the MPV database cross-references data from both The Washington Post and The Guardian (as well as from Fatal Encounters and Killed by Police).
Given that police killings of armed victims had neither statistically nor substantively significant effects on the mental health of the US general For more on the Behavioral Risk Factor Surveillance System see https://www.cdc.gov/brfss/index. html
Sodium bicarbonate for severe metabolic acidaemia
We read with great interest the Article by Samir Jaber and colleagues (June 14, 2018, p 31) 1 concerning treatment with sodium bicarbonate for patients with severe metabolic acidaemia in the intensive care unit. The conclusion was that sodium bicarbonate had no effect on the primary composite outcome or on the components of this composite outcome, the most important being mortality at 28 days, and there was no mention in the discussion, or in the Comment by Kraut and Madias, 2 that the study could have not had enough statistical power.
In our opinion, this study did not have enough statistical power to exclude important clinical effects: the absolute risk reduction of the composite outcome was 5·5%, possibly up to 15·2% (the lower limit of the CI). With respect to the hard endpoint of mortality at 28 days, the absolute risk reduction was 9% (number needed to treat [NNT] 12), possibly up to 19·4% (NNT five)-a huge effect on mortality (p=0·07, borderline). Moreover, in multivariate analysis, after adjusting for important clinical covariates, the effect of sodium bicarbonate on mortality at Jaber and colleagues 1 report the results of a thoughtfully designed trial examining sodium bicarbonate administration to critically ill adults with acidaemia. We congratulate the authors on this accomplishment and pose two questions.
First, the composite primary outcome chosen by the authors-28-day mortality or an organ failure at day 7-has important limitations. Components of the outcome are assessed at differing timepoints, dysfunction in organ systems mechanistically unrelated to the intervention are included in the composite (eg, haematological dysfunction), and the outcome's relevance to patients is unclear. For phase 3 clinical trials involving acute kidney injury, a National Institute of Diabetes and Digestive and Kidney Diseases work group has recommended as a patient-centred outcome the use of major adverse kidney eventsthe composite of death, new receipt of renal-replacement therapy, or persistent renal dysfunction (defined by plasma creatinine values or glomerular filtration rate).
2,3 Can the authors report what proportion of patients in each study group experienced a major adverse kidney event by 28 days (understanding that the data might be censored at hospital discharge)?
Second, one contributor to acidaemia among critically ill adults is receipt of 0·9% sodium chloride. What volume of intravenous fluid did patients receive before enrolment, and what proportion of that fluid was 0·9% sodium chloride? If bicarbonate administration in the trial was, in part, correcting salineinduced hyperchloremic metabolic acidosis, preferential use of balanced crystalloids for initial resuscitation might diminish the need for, and effect of, subsequent bicarbonate therapy. 4 We declare no competing interests.
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Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN, 37232, USA bicarbonate also might have spared saline use and reduced chlorine intake. These two effects would widen the difference in sodium and chlorine concentrations and increase both pH and bicarbonate, which were two of the three indications for dialysis. These criteria were also used more commonly to assess the need for dialysis in the control group than they were in the treatment group and drove the difference in dialysis use (table S8 of  the Article appendix) .
1 Yet, there is no evidence that treating a low pH alters haemodynamics. The use of the sodium bicarbonate solution probably calmed the clinicians because they did not feel that dialysis was necessary. Instead of a reflex dialysis response to acidaemia, what was needed was an understanding of the mechanism and treatment of the acidosis, which would have been a lot cheaper.
We declare no competing interests. 28 days became statistically significant (hazard ratio 0·727, 95% CI 0·54-0·98, p=0·035). Because this study was, apparently, the first randomised controlled trial on this treatment, a meta-analysis cannot be done. Therefore, we need larger trials to clearly identify the effect (or lack of it) of sodium bicarbonate in patients with severe metabolic acidaemia.
*Sheldon Magder, Gordan Samoukovic
I declare no competing interests. 4 The only effect of sodium bicarbonate that Jaber and colleagues found was decreased use of dialysis, which could have clinical value.
Cristian Baicus
5 But was dialysis necessary in all cases? In the physical and chemical analysis of acid-base abnormalities developed by Peter Stewart, 6,7 the difference in sodium and chlorine concentrations is a crucial determinant of pH and bicarbonite concentration. When sodium bicarbonate is given, the strong sodium ion remains free and carbon dioxide and bicarbonate are controlled by ventilation. Consistent with this process, mean carbon dioxide concentration did not change in Jaber and colleagues' study, 1 although the mean might have changed in patients with fixed ventilation. Use of sodium
